INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined mushrooms. Clear

8 studies

2021 / Prospective cohort study and meta-analysis of prospective cohort studies

In a meta-analysis of prospective cohort studies, mushroom intake was linked to a lower risk of all-cause mortality.

Researchers analyzed 30,378 NHANES participants over a mean follow-up of 6.7 years and conducted a meta-analysis combining these data with four other prospective cohort studies (totaling 601,893 individuals). In NHANES, mushroom consumption showed a non-significant association with all-cause mortality after multivariable adjustments (adjusted HR 0.84; 95% CI: 0.67-1.06; 2,855 deaths). However, the meta-analysis found that mushroom consumption was associated with a lower risk of all-cause mortality (pooled risk ratio 0.94; 95% CI: 0.91, 0.98).

Shows an association, not proof of cause and effect.

Ba DM, Gao X, Al-Shaar L, et al. Nutr J, 2021. PMID 34548082

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2016 / Retrospective analysis of a dietary intervention study

Daily white button mushroom intake for 16 weeks improved select antioxidant and anti-inflammatory markers in adults with metabolic syndrome.

Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.

Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019

2012 / Randomized controlled trial

Ergocalciferol from UV-treated mushrooms or supplements increased serum 25(OH)D2 but proportionally decreased 25(OH)D3, leaving total vitamin D unchanged.

Thirty-eight healthy adults were randomized to 4 groups consuming standard meals for 6 weeks: untreated mushrooms (control, 0.85 μg/d ergocalciferol), UV-treated mushrooms at 8.8 μg/d (M1) or 17.1 μg/d (M2), or purified ergocalciferol supplement plus untreated mushrooms (28.2 μg/d, S). At week 6, serum 25(OH)D2 increased by 1.2 ± 5.2 in C, 13.8 ± 7.3 in M1, 12.7 ± 3.7 in M2, and 32.8 ± 3.3 nmol/L in S. Concurrently, 25(OH)D3 decreased by -3.9 ± 16.3 in C, -10.4 ± 6.4 in M1, -20.6 ± 14.6 in M2, and -29.5 ± 15.9 nmol/L in S. Overall, ergocalciferol was absorbed and metabolized to 25(OH)D2 but did not affect overall vitamin D status because 25(OH)D3 decreased proportionally.

Stephensen CB, Zerofsky M, Burnett DJ, et al. J Nutr, 2012. PMID 22623385

2011 / 5-week, single-blinded, randomized, placebo-controlled trial

Vitamin D2 from UV-B-irradiated button mushrooms effectively raised serum 25-hydroxyvitamin D similarly to a vitamin D2 supplement in deficient adults.

In a 5-week trial during winter, 26 young adults with serum 25OHD <= 50 nmol/l were randomized to receive 28,000 IU (700 ug) vitamin D2 via an experimental mushroom soup, 28,000 IU vitamin D2 via a supplement, or placebo. After 2 weeks, serum 25OHD was significantly higher in the mushroom group than in the placebo group (P=0.001). Serum 25OHD concentrations rose significantly and similarly in the mushroom and supplement groups over the study period by 3.9 nmol/l per week (95% CI: 2.9, 4.8) and 4.7 nmol/l per week (95% CI: 3.8, 5.7), respectively.

Urbain P, Singler F, Ihorst G, et al. Eur J Clin Nutr, 2011. PMID 21540874

2008 / Case report

A patient with vitamin D deficiency experienced beneficial changes in plasma biochemical markers after consuming UVB-irradiated mushrooms.

A case report describes a patient with vitamin D deficiency who rejected standard treatment with a vitamin D-containing calcium supplement. The patient opted to self-treat by consuming UVB-irradiated mushrooms after researching alternative treatment options independently. A beneficial effect of consuming the mushrooms on the patient's plasma biochemical markers was reported.

Shows an association, not proof of cause and effect.

Ozzard A, Hear G, Morrison G, et al. Br J Gen Pract, 2008. PMID 18801283

2013 / Narrative review

Evaluating white vegetables solely by glycemic index is context-dependent and may provide misleading dietary guidance.

This review evaluates the effect of white vegetable consumption (such as potatoes, cauliflowers, turnips, onions, parsnips, white corn, kohlrabi, and mushrooms) on glycemia, satiety, and food intake. The author notes that white vegetables vary widely in their contribution to energy, nutrient content, glycemia, and satiety. Using the potato as an example, the glycemic index can be misleading if not interpreted within the context of total dietary carbohydrate, nutrient composition, and satiety effects in typical meals. The review concludes that applying the glycemic index in isolation to judge white vegetables has led to premature and potentially counterproductive dietary guidance.

Anderson GH, Soeandy CD, Smith CE Adv Nutr, 2013. PMID 23674805

2006 / Narrative review of systematic reviews and clinical experiments

A review examined the biomedical effects of dietary fiber beta-glucan from sources like barley, oats, yeast, and mushrooms.

Beta-glucan is a polysaccharide fiber found in grains such as barley, oats, yeast, and mushrooms. The authors reviewed systematic reviews and clinical experiments evaluating the biomedical effects of beta-glucan, including lipid lowering, blood sugar reduction, weight reduction, immune modulation, and anticarcinogenic effects. The review aimed to identify issues and help develop future research strategies.

Kim SY, Song HJ, Lee YY, et al. J Korean Med Sci, 2006. PMID 17043406